XERS — Xeris Biopharma Holdings Share News
0.000.00%
Last trade - 00:00- $1.84bn
- $1.97bn
- $291.85m
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Vor Biopharma, Fair Isaac Corp, Plug Power
Lundbeck expresses interest in buying Xeris, Bloomberg News reports (updated)
Xeris Biopharma rises on report of Lundbeck takeover interest
Lundbeck expresses interest in buying Xeris, Bloomberg News reports
Brief: Lundbeck Is Said To Express Interest In Buying Xeris Biopharma - Bloomberg News
Xeris Biopharma Holdings, Inc. reports results for the quarter ended June 30 - Earnings Summary
Xeris Biopharma Q2 revenue rises 34%, slightly beats estimates
Brief: Xeris Names John Shannon As Chair Of The Board
Brief: Xeris Biopharma Announces Private Exchange Of Convertible Notes
Xeris Biopharma Q1 product revenue jumps 43%, beats estimates
Brief: Xeris Biopharma Q4 Product Revenue USD 83.43 Million Versus. Ibes Estimate USD 82.3 Million
Xeris Biopharma Q4 product revenue beats analyst expectations, driven by higher patient demand
Brief: Xeris Biopharma Subsidiaries File Recorlev Patent Infringement Lawsuit
Brief: Xeris Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Xeris Biopharma Holdings Inc - Unit Receives Uspto Notice Of Allowance For Xp-8121 Patent
Xeris Q3 product revenue slightly misses; updates 2025 revenue guidance
Brief: Xeris Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule
Xeris Biopharma Holdings Inc reports results for the quarter ended June 30 - Earnings Summary